Prostate Cancer

Ashish M. Kamat, M.D., is a professor of Urology and director of Urologic Oncology Fellowship at The University of Texas MD Anderson Cancer Center, and a graduate of the AUA Leadership Program. Dr. Kamat’s expertise is in multidisciplinary management of urologic cancers with an emphasis bladder and prostate cancer, organ sparing therapies, minimally invasive techniques, and orthotopic bladder substitution (neobladder). While he is a busy surgeon, he maintains an active research portfolio to improve the care of patients. Dr. Kamat’s efforts are directed towards identifying predictors of response to therapy - especially immunotherapy - as a first step towards personalized cancer therapeutics. A major focus of his laboratory research is to develop novel treatments for bladder cancer and identify resistance mechanisms and ways to overcome them. He serves as project PI on the MD Anderson Cancer Center GU (Bladder) SPORE. Dr. Kamat has authored over 200 publications, editorials & book chapte

Brian Chapin, M.D., is an associate professor of Urology at The University of Texas MD Anderson Cancer Center in Houston, Texas. Learn more about Dr. Chapin: Request an appointment at MD Anderson by calling 1-877-632-6789 or online:

John Davis, M.D., discusses when men should begin prostate cancer screening. MD Anderson recommends men age 50 to 75 discuss screening risks and benefits with your health care provider. A digital rectal exam, along with a prostate-specific antigen (PSA), is recommended every year, if you choose to be screened. MD Anderson doesn’t recommend cancer screening for men age 85 or older Men at increased risk are more likely to get prostate cancer. This doesn’t mean you’ll definitely get cancer. But, you may need to start screening at an earlier age, get additional tests or be tested more often. You’re at increased risk if you have a family history (especially father, brother, son) of prostate cancer, or are African-American. Find out more about prostate screenings